Video

ACC 2017 : PCSK9 Inhibition in Subjects With Elevated Risk

Published: 10 Mar 2017

  • Views:

    Views Icon 348

  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

 

FOURIER - Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk.

Interview with Professor Peter Sever from Imperial College London, London, UK at ACC 2017.